Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cryptococcal Antigen Screening Plus Sertraline

NCT03002012 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT03002012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03002012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cryptococcal Antigen Screening Plus Sertraline
Lead sponsor
University of Minnesota
Phase
Phase 3
Overall status
Terminated
Start date
November 15, 2017
Completion date
March 13, 2018
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aids-related opportunistic infections, cryptococcal infections, cryptococcosis